Onconova Therapeutics Inc

NASDAQ:ONTX   1:56:05 PM EDT
3.81
-0.16 (-4.15%)
Earnings Announcements

Onconova Therapeutics Reports Second Quarter 2021 Financial Results

Published: 08/12/2021 22:00 GMT
Onconova Therapeutics Inc (ONTX) - Onconova Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update.
Q2 Loss per Share $0.27.
Cash and Cash Equivalents As of June 30, 2021 Were $43.7 Million.
Onconova Therapeutics - Believes Cash and Cash Equivalents Will Be Sufficient to Fund Ongoing Clinical Trials & Business Operations for More Than 18 Months.
Revenue is expected to be $0.05 Million
Adjusted EPS is expected to be -$0.40

Next Quarter Revenue Guidance is expected to be $0.06 Million
Next Quarter EPS Guidance is expected to be -$0.54

More details on our Analysts Page.